Search Results for "Leuprolide Biomarkers Breast"
Original Source: Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy
RATIONALE: Androgens can cause the growth of prostate cancer cells. Antihormone therapy, such as goserelin acetate and leuprolide acetate, may lessen the amount of androgens made by the body and thus control prostate cancer growth. Many times, after surgery, the tumor may not need more treatment until it progresses. In this case, observation may be sufficient. However in some prostate cancers there is a chance that tumors can re-grow despite surgery based on certain high risk...
Matching Channels
Breast cancer in the UK is diagnosed in nearly 46,000 people each year, with just over 12,000 dying from breast cancer each year in he UK. There are several risk factors for developing b...
Luteinizing hormone (LH), a gonadotropin, stimulates the gonads - in males, the testes, and in females, the ovaries. It is essential for reproduction, and secreted from cells in the anterior pituita...
Selective Estrogen Receptor Modulators SERMs
Selective estrogen receptor modulators (SERMs) act as estrogen receptor (ER) agonists or antagonist depending on the targeted tissue and the specific configuration of the used SERM. Effects on bone, e...
Matching News
Foresee, ScinoPharm to form joint venture for new oncological Leuprolide injectable drug
ScinoPharm and Foresee Pharmaceuticals, Inc. jointly announced today that an investment agreement to form a joint venture has been signed. This venture looks to develop a series of peptide injectable...
Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?
Most studies for identifying biomarkers for oestrogen receptor-α (ERα)-positive breast cancer have been performed using material from consecutive series of patients treated with tamoxifen. Consequen...
HALO, UND enter agreement to develop biomarkers for early detection of breast cancer
HALO Healthcare, Inc., a provider of innovative diagnostic solutions for women's breast care announced that it has signed a definitive license agreement with the University of North Dakota (UND) to de...
Verastem (NASDAQ: VSTM) Presentation of Preclinical data at the ASCO
Data on novel biomarkers that may enable improved discrimination of cancer stem cells from other cancer cells and normal tissue. VSTM will describe the use of multiple methodologies, including...
Physical activity has no relation with risk of non-invasive breast cancer
A European study published in the 'Cancer Epidemiology, Biomarkers & Prevention' journal has analysed the association between physical activities and in situ or non-invasive breast cancer, or, in othe...
Diet and exercise reduce breast cancer biomarkers
NEW YORK (Reuters Health) - For overweight women, another advantage of weight loss may be that it lowers their exposure to biomarkers associated with breast cancer, researchers say.
Physical activity does not protect against in situ breast cancer, epidemiological study says
A European study published in the Cancer Epidemiology, Biomarkers & Prevention journal has analysed the association between physical activities and in situ or non-invasive breast cancer, or, in other...
A women’s health care company in turnaround – one well recognized for assessing a woman’s risk of developing breast cancer through the HALO breast test – is developing a breast cancer diagnost...
Matching PubMed Articles
Goserelin versus leuprolide in the chemical castration of patients with prostate cancer.
PURPOSE: To evaluate the relative efficiency of leuprolide 3.75 mg, leuprolide 7.5 mg, and goserelin 3.6 mg in relation to the reduction in serum testosterone, regarding the l...
It was the aim of this study to develop a nanoparticulate oral drug delivery system for leuprolide based on polyacrylic acid (PAA). In order to achieve formation of nanoparticles in a mild, aqueous en...
Ulipristal acetate versus leuprolide acetate for uterine fibroids.
The efficacy and side-effect profile of ulipristal acetate as compared with those of leuprolide acetate for the treatment of symptomatic uterine fibroids before surgery are unclear.
To report an unanticipated pregnancy during ovarian ablation treatment with goserelin (10.8 mg SC every 12 weeks) in a 26-year old female with breast cancer. Review of the current literature and rep...
The aim of this study was to compare tumor expression of prognostic biomarkers between interval breast cancers and screen-detected breast cancers overall, and according to age at diagnosis and familia...
